Disorder-to-order conformational transitions in protein structure and its relationship to disease

Molecular and Cellular Biochemistry

Volumn 330, Issue 1-2, 2009, Pages 105-120

  Mendoza Espinosa, Paola ^a   García González, Victor ^a   Moreno, Abel ^a   Castillo, Rolando ^a   Mas Oliva, Jaime ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Disease; Disorder to order transitions; Protein misfolding; Protein structure

Indexed keywords

AMYLIN; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; CHOLESTEROL ESTER TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; FATAL FAMILIAL INSOMNIA; GENE ACTIVATION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HYDROPHOBICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PHYSICAL CHEMISTRY; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 73349119086     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0105-6     Document Type: Review

References (212)

1. L Beretta 2007 Proteomics from the clinical perspective: many hopes and much debate Nat Methods 4 785 786 10.1038/nmeth1007-785 17901867 1:CAS:528:DC%2BD2sXhtV2mtr%2FF 10.1038/nmeth1007-785 (Pubitemid 350055574)
2. GD Rose PJ Fleming JR Banavar A Maritan 2006 A backbone-based theory of protein folding Proc Natl Acad Sci USA 103 16623 16633 10.1073/pnas.0606843103 17075053 1:CAS:528:DC%2BD28Xht1egtbnN 10.1073/pnas.0606843103 (Pubitemid 44737304)
3. WA Eaton V Muñoz SJ Hagen GS Jas LJ Lapidus ER Henry 2000 Fast kinetics and mechanisms in protein folding Annu Rev Biophys Biomol Struct 29 327 359 10.1146/annurev.biophys.29.1.327 10940252 1:CAS:528:DC%2BD3cXlsFOnuro%3D 10.1146/annurev.biophys.29.1.327 (Pubitemid 30599597)
4. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331 10.1016/S0092-8674(00)81871-1 9039259 1:CAS:528:DyaK2sXhtFahtLg%3D 10.1016/S0092-8674(00)81871-1 (Pubitemid 27131374)
5. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 10.1038/35042675 11099028 1:CAS:528:DC%2BD3cXosVemtrY%3D 10.1038/35042675
6. A Quist I Doudevski H Lin R Azimova D Ng B Frangione B Kagan J Ghiso R Lal 2005 Amyloid ion channels: a common structural link for protein-misfolding disease Proc Natl Acad Sci USA 102 10427 10432 10.1073/pnas.0502066102 16020533 1:CAS:528:DC%2BD2MXntVSit7w%3D 10.1073/pnas.0502066102 (Pubitemid 41061570)
7. PS Frenette GF Atweh 2007 Sickle cell disease: old discoveries, new concepts, and future promise J Clin Invest 117 850 858 10.1172/JCI30920 17404610 1:CAS:528:DC%2BD2sXktVOisLk%3D 10.1172/JCI30920 (Pubitemid 46556737)
8. AT Petkova RD Leapman Z Guo WM Yau MP Mattson R Tycko 2005 Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils Science 307 262 265 10.1126/science.1105850 15653506 1:CAS:528:DC%2BD2MXisVKksA%3D%3D 10.1126/science.1105850 (Pubitemid 40116242)
9. HM Yull DL Ritchie JP Langeveld FG van Zijderveld ME Bruce JW Ironside MW Head 2006 Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease Am J Pathol 168 151 157 10.2353/ajpath.2006.050766 16400018 1:CAS:528:DC%2BD28XhtVKksb0%3D 10.2353/ajpath.2006.050766 (Pubitemid 43062568)
10. DJ Selkoe 2003 Folding proteins in fatal ways Nature 426 900 904 10.1038/nature02264 14685251 1:CAS:528:DC%2BD3sXpvVGmur4%3D 10.1038/nature02264 (Pubitemid 38056883)
11. M Hoenig G Hall D Ferguson K Jordan M Henson K Johnson T O'Brien 2000 A feline model of experimentally induced islet amyloidosis Am J Pathol 157 2143 2150 11106586 1:STN:280:DC%2BD3M%2FntFGrtw%3D%3D
12. Huang K (2005) Lectures on statistical physics and protein folding. World Scientific, New Jersey
13. CM Dobson 2003 Protein folding and misfolding Nature 426 884 890 10.1038/nature02261 14685248 1:CAS:528:DC%2BD3sXpvVGmtbk%3D 10.1038/nature02261 (Pubitemid 38056880)
14. J Gsponer M Vendruscolo 2006 Theoretical approaches to protein aggregation Protein Pept Lett 13 287 293 10.2174/092986606775338407 16515457 1:CAS:528:DC%2BD28Xit1Sjsbo%3D 10.2174/092986606775338407
15. CM Dobson 1999 Protein misfolding, evolution and disease Trends Biochem Sci 24 329 332 10.1016/S0968-0004(99)01445-0 10470028 1:CAS:528: DyaK1MXls1ygtLg%3D 10.1016/S0968-0004(99)01445-0 (Pubitemid 29421804)
16. D Eisenberg R Nelson MR Sawaya M Balbirnie S Sambashivan MI Ivanova AO Madsen C Riekel 2006 The structural biology of protein aggregation diseases: fundamental questions and some answers Acc Chem Res 39 568 575 10.1021/ar0500618 16981672 1:CAS:528:DC%2BD28XptFajtbY%3D 10.1021/ar0500618
17. AL Fink 1998 Protein aggregation: folding aggregates, inclusion bodies and amyloid Fold Des 3 R9 R23 10.1016/S1359-0278(98)00002-9 9502314 1:CAS:528:DyaK1cXhtFSks7o%3D 10.1016/S1359-0278(98)00002-9 (Pubitemid 28085702)
18. S Chandra X Chen J Rizo R Jahn TC Südhof 2003 A broken alpha-helix in folded alpha-synuclein J Biol Chem 278 15313 15318 10.1074/jbc.M213128200 12586824 1:CAS:528:DC%2BD3sXjtVCltr0%3D 10.1074/jbc.M213128200 (Pubitemid 36799869)
19. MC Dobson 2004 Protein chemistry: in the footsteps of alchemists Science 304 1259 1262 10.1126/science.1093078 15166354 1:CAS:528:DC%2BD2cXksFWku78%3D 10.1126/science.1093078 (Pubitemid 38697410)
20. S Ohnishi K Takano 2004 Amyloid fibrils from the viewpoint of protein folding Cell Mol Life Sci 61 511 524 10.1007/s00018-003-3264-8 15004691 1:CAS:528:DC%2BD2cXjt1OrsrY%3D 10.1007/s00018-003-3264-8 (Pubitemid 38372906)
21. S Chen FA Ferrone R Wetzel 2002 Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation Proc Natl Acad Sci USA 99 11884 11889 10.1073/pnas.182276099 12186976 1:CAS:528:DC%2BD38XntFWqtLc%3D 10.1073/pnas.182276099 (Pubitemid 34994493)
22. X Wang A Vitalis MA Wyczalkowski RV Pappu 2006 Characterizing the conformational ensemble of monomeric polyglutamine Proteins 63 297 311 10.1002/prot.20761 16299774 1:CAS:528:DC%2BD28XjtlKit7g%3D 10.1002/prot.20761
23. W Bode R Huber 1976 Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin FEBS Lett 68 231 236 10.1016/0014-5793(76)80443-7 10181 1:CAS:528:DyaE28Xlslentro%3D 10.1016/0014-5793(76)80443-7
24. R Huber W Bode 1978 Structural basis of the activation and action of trypsin Acc Chem Res 11 114 122 10.1021/ar50123a006 1:CAS:528:DyaE1cXhtVSlu70%3D 10.1021/ar50123a006
25. AK Dunker JD Lawson CJ Brown RM Williams P Romero JS Oh CJ Oldfield AM Campen CM Ratliff KW Hipps J Ausio MS Nissen R Reeves C Kang CR Kissinger RW Bailey MD Griswold W Chiu EC Garner ZJ Obradovic 2001 Intrinsically disordered protein J Mol Graph Model 19 26 59 10.1016/S1093-3263(00)00138-8 11381529 1:CAS:528:DC%2BD3MXjtFGmsro%3D 10.1016/S1093-3263(00)00138-8 (Pubitemid 32411501)
26. AK Dunker Z Obradovic 2001 The protein trinity-linking function and disorder Nat Biotechnol 19 805 806 10.1038/nbt0901-805 11533628 1:CAS:528:DC%2BD3MXmvVWrtLc%3D 10.1038/nbt0901-805 (Pubitemid 32816745)
27. VN Uversky 2002 Natively unfolded proteins: a point where biology waits for physics Protein Sci 11 739 756 10.1110/ps.4210102 11910019 1:CAS:528:DC%2BD38Xis1Wmu74%3D 10.1110/ps.4210102 (Pubitemid 34241284)
28. P Tompa 2002 Intrinsically unstructured proteins Trends Biochem Sci 27 527 533 10.1016/S0968-0004(02)02169-2 12368089 1:CAS:528:DC%2BD38XnsVWqsbo%3D 10.1016/S0968-0004(02)02169-2 (Pubitemid 35279598)
29. C James DS Tawfik 2003 Conformational diversity and protein evolution-a 60-year-old hypothesis revisited Trends Biochem Sci 28 361 368 10.1016/S0968-0004(03)00135-X 12878003 1:CAS:528:DC%2BD3sXls1CjtbY%3D 10.1016/S0968-0004(03)00135-X (Pubitemid 36851617)
30. DM Bustos AA Iglesias 2006 Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins Proteins 63 35 42 10.1002/prot.20888 16444738 1:CAS:528:DC%2BD28Xis1Cgu78%3D 10.1002/prot.20888
31. RW Kriwacki L Hengst L Tennant SI Reed PE Wright 1996 Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity Proc Natl Acad Sci USA 93 11504 11509 10.1073/pnas.93.21.11504 8876165 1:CAS:528:DyaK28Xmtlagtrc%3D 10.1073/pnas.93.21.11504 (Pubitemid 26347151)
32. S Dalal L Regan 2000 Understanding the sequence determinants of conformational switching using protein design Protein Sci 9 1651 1659 10.1110/ps.9.9.1651 11045612 1:CAS:528:DC%2BD3cXntFams7w%3D 10.1110/ps.9.9.1651
33. K Pagel T Vagt B Koksch 2005 Directing the secondary structure of polypeptides at will: from helices to amyloids and back again? Org Biomol Chem 3 3843 3850 10.1039/b510098d 16239998 1:CAS:528:DC%2BD2MXht1ehtLfF 10.1039/b510098d
34. E Polverini A Fasano F Zito P Riccio P Cavatorta 1999 Conformation of bovine myelin basic protein purified with bound lipids Eur Biophys J 28 351 355 10.1007/s002490050218 10394626 1:CAS:528:DyaK1MXjtFKiur4%3D 10.1007/ s002490050218 (Pubitemid 29260137)
35. Dunker AK, Garner E, Guilliot S, Romero P, Albrecht K, Hart J, Obradovic Z, Kissinger C, Villafranca JE (1998) Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput 473-484
36. M Sickmeier JA Hamilton T LeGall V Vacic MS Cortese A Tatos B Szabo P Tompa J Chen VN Uversky Z Obradovic AK Dunker 2007 DisProt: the database of disordered proteins Nucleic Acids Res 35 D786 D793 10.1093/nar/gkl893 17145717 1:CAS:528:DC%2BD2sXivFKisw%3D%3D 10.1093/nar/gkl893 (Pubitemid 46056310)
37. MS Cortese VN Uversky AK Dunker 2008 Intrinsic disorder in scaffold proteins: getting more from less Prog Biophys Mol Biol 98 85 106 10.1016/j.pbiomolbio.2008.05.007 18619997 1:CAS:528:DC%2BD1cXhtVKjtbfO 10.1016/j.pbiomolbio.2008.05.007
38. C-T Su C-Y Chen C-M Hsu 2007 iPDA: integrated protein disorder analyzer Nucleic Acids Res 35 W465 W472 10.1093/nar/gkm080 17553839 10.1093/nar/gkm353 (Pubitemid 47073622)
39. O Conchillo-Solé NS de Groot FX Avilés J Vendrell X Daura S Ventura 2007 AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides BMC Bioinformatics 8 65 10.1186/1471-2105-8-65 17324296 10.1186/1471-2105-8-65 1:CAS:528: DC%2BD2sXksFGqsrg%3D (Pubitemid 46470288)
40. PZ Romero C Obradovic AK Dunker 2001 Intelligent data analysis for protein disorder prediction Artif Intell Rev 14 447 484 10.1023/A:1006678623815 10.1023/A:1006678623815
41. VN Uversky 2002 What does it mean to be natively unfolded? Eur J Biochem 269 2 12 10.1046/j.0014-2956.2001.02649.x 11784292 1:CAS:528: DC%2BD38XosFCqtg%3D%3D 10.1046/j.0014-2956.2001.02649.x (Pubitemid 34107333)
42. Y Cheng T LeGall CJ Oldfield JP Mueller YY Van P Romero MS Cortese VN Uversky AK Dunker 2006 Rational drug design via intrinsically disordered protein Trends Biotechnol 24 435 442 10.1016/j.tibtech.2006.07.005 16876893 1:CAS:528:DC%2BD28Xps1Oisrg%3D 10.1016/j.tibtech.2006.07.005 (Pubitemid 44374778)
43. Q Xie GE Arnold P Romero Z Obradovic E Garner AK Dunker 1998 The sequence attribute method for determining relationships between sequence and protein disorder Genome Inform Ser Workshop Genome Inform 9 193 200 11072335 1:CAS:528:DyaK1MXhslGnsLY%3D
44. P Romero Z Obradovic X Li EC Garner CJ Brown AK Dunker 2001 Sequence complexity of disordered protein Proteins 42 38 48 10.1002/1097-0134(20010101) 42:1<38::AID-PROT50>3.0.CO;2-3 11093259 1:CAS:528:DC%2BD3MXitVWgtA%3D%3D 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3 (Pubitemid 32015215)
45. AK Dunker CJ Brown JD Lawson LM Iakoucheva Z Obradovic 2002 Intrinsic disorder and protein function Biochemistry 41 6573 6582 10.1021/bi012159+ 12022860 1:CAS:528:DC%2BD38Xjt1aitbc%3D 10.1021/bi012159+ (Pubitemid 34547347)
46. W Held H Clevers R Grosschedl 2003 Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition Eur J Immunol 33 1393 1398 10.1002/eji.200323840 12731066 1:CAS:528:DC%2BD3sXjvFyjsL4%3D 10.1002/eji.200323840 (Pubitemid 36609158)
47. JJ Love X Li J Chung HJ Dyson PE Wright 2004 The LEF-1 high-mobility group domain undergoes a disorder-to-order transition upon formation of a complex with cognate DNA Biochemistry 43 8725 8734 10.1021/bi049591m 15236581 1:CAS:528:DC%2BD2cXksl2kurs%3D 10.1021/bi049591m (Pubitemid 38880043)
48. JM Birch AL Hartley KJ Tricker J Prosser A Condie AM Kelsey M Harris PH Jones A Binchy D Crowther AW Craft PB Edem DGR Evans E Thompson JR Mann J Martin ELD Mithel F Santibáñez-Koref 1994 Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families Cancer Res 54 1298 1304 8118819 1:CAS:528:DyaK2cXitFCjsbY%3D
49. M Olivier DE Goldgar N Sodha H Ohgaki P Kleihues P Hainaut RA Eeles 2003 Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype Cancer Res 63 6643 6650 14583457 1:CAS:528:DC%2BD3sXosVGgurs%3D
50. AC Martin AM Facchiano AL Cuff T Hernandez-Boussard M Olivier P Hainaut JM Thornton 2002 Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein Hum Mutat 19 149 164 10.1002/humu.10032 11793474 1:CAS:528:DC%2BD38XhsVKrsLo%3D 10.1002/humu.10032 (Pubitemid 34121806)
51. D Ishimaru LMTR Lima LF Naia PM Lopez APA Bom AP Valente JL Silva 2004 Reversible aggregation plays a crucial role on the folding landscape of p53 core domain Biophys J 87 2691 2700 10.1529/biophysj.104.044685 15298872 1:CAS:528:DC%2BD2cXot12msb4%3D 10.1529/biophysj.104.044685
52. R Ivanyi-Nagy L Davidovic EW Khandjian JL Darlix 2005 Disordered RNA chaperone proteins: from functions to disease Cell Mol Life Sci 62 1409 1417 10.1007/s00018-005-5100-9 15924259 1:CAS:528:DC%2BD2MXhtFCgs7nJ 10.1007/s00018-005-5100-9 (Pubitemid 40922944)
53. P Tompa P Csermely 2004 The role of structural disorder in the function of RNA and protein chaperones FASEB J 18 1169 1175 10.1096/fj.04-1584rev 15284216 1:CAS:528:DC%2BD2cXmsVaht78%3D 10.1096/fj.04-1584rev (Pubitemid 39006878)
54. Y Mély H De Rocquigny N Morellet BP Roques D Gerad 1996 Zinc binding to the HIV-1 nucleocapsid protein: a thermodynamic investigation by fluorescence spectroscopy Biochemistry 35 5175 5182 10.1021/bi952587d 8611501 10.1021/bi952587d (Pubitemid 26129458)
55. TL South PR Blake RC Sowder 3rd LO Arthur LE Henderson MF Summers 1990 The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers Biochemistry 29 7786 7789 10.1021/bi00486a002 2261434 1:CAS:528:DyaK3cXltFWitrs%3D 10.1021/bi00486a002 (Pubitemid 20281223)
56. S Carteau RJ Gorelick FD Bushman 1999 Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein J Virol 73 6670 6679 10400764 1:CAS:528:DyaK1MXksFKntbg%3D
57. G Cristofari JL Darlix 2002 The ubiquitous nature of RNA chaperone proteins Prog Nucleic Acid Res Mol Biol 72 223 268 10.1016/S0079-6603(02)72071-0 12206453 1:CAS:528:DC%2BD38XotFOgtLs%3D 10.1016/S0079-6603(02)72071-0
58. Z Tsuchihashi PO Brown 1994 DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein J Virol 68 5863 5870 8057466 1:CAS:528:DyaK2cXlslajurY%3D
59. MR Hargittai RJ Gorelick I Rouzina K Musier-Forsyth 2004 Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site J Mol Biol 337 951 968 10.1016/j.jmb.2004. 01.054 15033363 1:CAS:528:DC%2BD2cXitFKmsro%3D 10.1016/j.jmb.2004.01.054 (Pubitemid 38368937)
60. MA Urbaneja M Wu JR Casas-Finet RL Karpel 2002 HIV-1 nucleocapsid protein as a nucleic acid chaperone: spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity J Mol Biol 318 749 764 10.1016/S0022-2836(02)00043-8 12054820 1:CAS:528: DC%2BD38Xks1Krs7k%3D 10.1016/S0022-2836(02)00043-8 (Pubitemid 34729366)
61. MC Williams I Rouzina JR Wenner RJ Gorelick K Musier-Forsyth VA Bloomfield 2001 Mechanism for nucleic acid chaperone activity of HIV-1 nucleocapsid protein revealed by single molecule stretching Proc Natl Acad Sci USA 98 6121 6126 10.1073/pnas.101033198 11344257 1:CAS:528:DC%2BD3MXktVWks78%3D 10.1073/pnas.101033198 (Pubitemid 32488203)
62. F Dib-Hajj R Khan DP Giedroc 1993 Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity Protein Sci 2 231 243 8443601 1:CAS:528:DyaK3sXhvVKiu7s%3D
63. BI Kankia G Barany K Musier-Forsyth 2005 Unfolding of DNA quadruplexes induced by HIV-1 nucleocapsid protein Nucleic Acids Res 33 4395 4403 10.1093/nar/gki741 16077025 1:CAS:528:DC%2BD2MXovVKqtr8%3D 10.1093/nar/gki741 (Pubitemid 41222554)
64. SP Stoylov C Vuilleumier E Stoylova H De Rocquigny BP Roques D Gérard Y Mély 1997 Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein Biopolymers 41 301 312 10.1002/(SICI)1097-0282(199703)41:3<301::AID-BIP5>3.0.CO;2-W 9057495 1:CAS:528:DyaK2sXhsVajs7o%3D 10.1002/(SICI)1097-0282(199703)41:3<301::AID- BIP5>3.0.CO;2-W (Pubitemid 27114171)
65. RN De Guzman ZR Wu CC Stalling L Pappalardo PN Borer MF Summers 1998 Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element Science 279 384 388 10.1126/science.279.5349.384 9430589 10.1126/science.279.5349.384 (Pubitemid 28063374)
66. GK Amarasinghe RN De Guzman RB Turner KJ Chancellor ZR Wu MF Summers 2000 NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition J Mol Biol 301 491 511 10.1006/jmbi.2000.3979 10926523 1:CAS:528:DC%2BD3cXltlCjsb8%3D 10.1006/jmbi.2000.3979 (Pubitemid 30738733)
67. GK Amarasinghe J Zhou M Miskimon KJ Chancellor JA McDonald AG Matthews RR Miller MD Rouse MF Summers 2001 Stem-loop SL4 of the HIV-1 psi RNA packaging signal exhibits weak affinity for the nucleocapsid protein. Structural studies and implications for genome recognition J Mol Biol 314 961 970 10.1006/jmbi.2000.5182 11743714 1:CAS:528:DC%2BD3MXptVOmurc%3D 10.1006/jmbi.2000.5182 (Pubitemid 34073061)
68. C Tisné BP Roques F Dardel 2001 Heteronuclear NMR studies of the interaction of tRNA(Lys)3 with HIV-1 nucleocapsid protein J Mol Biol 306 443 454 10.1006/jmbi.2000.4391 11178904 10.1006/jmbi.2000.4391 1:CAS:528: DC%2BD3MXhtFKrur4%3D (Pubitemid 33027714)
69. PE Johnson RB Turner ZR Wu L Hairston J Guo JG Levin MF Summers 2000 A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription Biochemistry 39 9084 9091 10.1021/bi000841i 10924101 1:CAS:528:DC%2BD3cXlsFShs7Y%3D 10.1021/bi000841i (Pubitemid 30626301)
70. S Bourbigot N Ramalanjaona C Boudier GF Salgado BP Roques Y Mély S Bouaziz N Morellet 2008 How the HIV-1 nucleocapsid protein binds and destabilises the (-)primer binding site during reverse transcription J Mol Biol 383 1112 1128 10.1016/j.jmb.2008.08.046 18773912 1:CAS:528:DC%2BD1cXht1KntrjF 10.1016/j.jmb.2008.08.046
71. J Xicohtencatl-Cortes R Castillo J Mas-Oliva 2004 In search of new structural states of exchangeable apolipoproteins Biochem Biophys Res Commun 324 467 470 10.1016/j.bbrc.2004.09.045 15474451 1:CAS:528:DC%2BD2cXotlCnu74%3D 10.1016/j.bbrc.2004.09.045 (Pubitemid 39345541)
72. VM Bolaños-García J Mas-Oliva S Ramos R Castillo 1999 Phase transitions in monolayers of human apolipoprotein C-I J Phys Chem B 103 6236 6242 10.1021/jp984342r 10.1021/jp984342r 1:CAS:528:DyaK1MXktlarurk%3D
73. VM Bolaños-García S Ramos J Xicohtencatl-Cortés R Castillo J Mas-Oliva 2001 Monolayers of apolipoproteins at the air/water interface J Phys Chem B 105 5757 5765 10.1021/jp010714b 10.1021/jp010714b 1:CAS:528:DC%2BD3MXksVShtLc%3D (Pubitemid 35339142)
74. Mas-Oliva J, Moreno A, Ramos S, Xicohtencatl-Cortés J, Campos J, Castillo R (2003) Frontiers in cardiovascular health. In: Dhalla NS et al (eds) Monolayers of apolipoprotein AII at the air/water interface. Kluwer, Dordrecht, pp 341-352
75. J Xicohtencatl-Cortes J Mas-Oliva R Castillo 2004 Phase transitions of phospholipid monolayers penetrated by apolipoproteins J Phys Chem B 108 7307 7315 10.1021/jp0369443 1:CAS:528:DC%2BD2cXjsVOitLw%3D 10.1021/jp0369443
76. J Ruíz-García A Moreno G Brezesinski H Möhwald J Mas-Oliva R Castillo 2003 Phase transitions, conformational changes in monolayers of human apolipoprotein CI and AII J Phys Chem B 107 11117 11124 10.1021/jp034801a 10.1021/jp034801a 1:CAS:528:DC%2BD3sXnt1Kksrc%3D
77. J Campos-Terán J Mas-Oliva R Castillo 2004 Interactions and conformations of α-helical human apolipoprotein CI on hydrophilic and on hydrophobic substrates J Phys Chem B 108 20442 20450 10.1021/jp048305d 10.1021/jp048305d 1:CAS:528:DC%2BD2cXhtVWhsb%2FE (Pubitemid 40073562)
78. S Ramos J Campos-Terán J Mas-Oliva T Nylander R Castillo 2008 Forces between hydrophilic surfaces adsorbed with apolipoprotein AII alpha helices Langmuir 24 8568 8575 10.1021/la800348y 18652418 1:CAS:528: DC%2BD1cXovVOhtLY%3D 10.1021/la800348y
79. P Mendoza-Espinosa A Moreno R Castillo J Mas-Oliva 2008 Lipid dependant disorder-to-order conformational transitions in apolipoprotein CI derived peptides Biochem Biophys Res Commun 365 8 15 10.1016/j.bbrc.2007.10.112 17967413 1:CAS:528:DC%2BD2sXhtlalsL%2FJ 10.1016/j.bbrc.2007.10.112 (Pubitemid 350102447)
80. K Conde-Knape A Bensadoun JH Sobel JS Cohn NS Shachter 2002 Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase J Lipid Res 43 2136 2145 10.1194/jlr.M200210-JLR200 12454276 1:CAS:528:DC%2BD38XpslGjs7g%3D 10.1194/jlr.M200210-JLR200 (Pubitemid 35471082)
81. J Poensgen 1990 Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes Biochim Biophys Acta 1042 188 192 2302419 1:CAS:528:DyaK3cXhslClsbg%3D
82. PK Kinnunen C Ehnolm 1976 Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase FEBS Lett 65 354 357 10.1016/0014-5793(76)80145-7 182536 1:CAS:528:DyaE28XksFylurk%3D 10.1016/0014-5793(76)80145-7
83. AK Soutar CW Garner HN Baker JT Sparrow RL Jackson AM Gotto LC Smith 1975 Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase Biochemistry 14 3057 3064 10.1021/bi00685a003 167813 1:CAS:528:DyaE2MXkslCms74%3D 10.1021/bi00685a003
84. T Gautier D Masson JP de Barros A Athias P Gambert D Aunis MH Metz-Boutique L Lagrost 2000 Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity J Biol Chem 275 37504 37509 10.1074/jbc.M007210200 10978346 1:CAS:528:DC%2BD3cXoslWgsbw%3D 10.1074/jbc.M007210200 (Pubitemid 32004858)
85. L Dumont T Gautier JP de Barros H Laplanche D Blache P Ducoroy J Fruchart JC Fruchart P Gambert D Masson L Lagrost 2005 Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI J Biol Chem 28 38108 38116 10.1074/jbc.M504678200 10.1074/jbc.M504678200 1:CAS:528:DC%2BD2MXhtF2is7zF (Pubitemid 41642426)
86. RC Kowal J Herz JL Goldstein V Esser MS Brown 1989 Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins Proc Natl Acad Sci USA 86 5810 5814 10.1073/pnas.86.15.5810 2762297 1:CAS:528:DyaL1MXltlWgt7s%3D 10.1073/pnas.86.15.5810
87. RC Kowal J Herz KH Weisgraber RW Mahley MS Brown JL Goldstein 1990 Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein J Biol Chem 265 10771 10779 2355022 1:CAS:528:DyaK3cXkvFems7g%3D
88. KH Weisgraber RW Mahley RC Kowal J Herz JL Goldstein MS Brown 1990 Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein J Biol Chem 265 22453 22459 2266137 1:CAS:528:DyaK3cXmt1ymtb4%3D
89. AD Roses 1996 Apolipoprotein E alleles as risk factors in Alzheimer's disease Annu Rev Med 47 387 400 10.1146/annurev.med.47.1.387 8712790 1:CAS:528:DyaK28XitlSntLs%3D 10.1146/annurev.med.47.1.387 (Pubitemid 26138899)
90. M Morishima-Kawashima N Oshima H Ogata H Yamaguchi M Yoshimura S Sugihara Y Ihara 2000 Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain Am J Pathol 157 2093 2099 11106581 1:CAS:528:DC%2BD3MXhsVOjsQ%3D%3D
91. A Andreola V Bellotti S Giorgetti P Mangione L Obici M Stoppini J Torres E Monzani G Merlini M Sunde 2003 Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I J Biol Chem 278 2444 2451 10.1074/jbc.M204801200 12421824 1:CAS:528:DC%2BD3sXksFantg%3D%3D 10.1074/jbc.M204801200 (Pubitemid 36801320)
92. P Westermark G Mucchiano T Marthin KH Johnson K Sletten 1995 Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques Am J Pathol 147 1186 1192 7485381 1:CAS:528:DyaK28XktVynsQ%3D%3D
93. T Ban M Hoshino S Takahashi D Hamada K Hasegawa H Naike Y Goto 2004 Direct observation of Abeta amyloid fibril growth and inhibition J Mol Biol 344 757 767 10.1016/j.jmb.2004.09.078 15533443 1:CAS:528:DC%2BD2cXpsVKisbg%3D 10.1016/j.jmb.2004.09.078 (Pubitemid 39469218)
94. J Collinge 2001 Prion diseases of humans and animals: their causes and molecular basis Annu Rev Neurosci 24 519 550 10.1146/annurev.neuro.24.1.519 11283320 1:CAS:528:DC%2BD3MXls1Shs7s%3D 10.1146/annurev.neuro.24.1.519 (Pubitemid 32695238)
95. N Manzano-León J Mas-Oliva 2006 Estrés Oxidativo, Péptido β-amiloide y Enfermedad de Alzheimer Gac Med Mex 142 229 238 16875352
96. X Zhu MA Smith K Honda G Aliev PI Moreira A Nunomura G Casadesus PL Harris SL Siedlak G Perry 2007 Vascular oxidative stress in Alzheimer disease J Neurol Sci 257 240 246 10.1016/j.jns.2007.01.039 17337008 1:CAS:528: DC%2BD2sXmtlWgur0%3D 10.1016/j.jns.2007.01.039 (Pubitemid 46856513)
97. KL Lazar H Miller-Auer GS Getz JP Orgel SC Meredith 2005 Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure Biochemistry 44 12681 12689 10.1021/bi0509705 16171382 1:CAS:528: DC%2BD2MXpt1Cntr4%3D 10.1021/bi0509705 (Pubitemid 41377308)
98. SX Zhang-Nunes ML Maat-Schieman SG van Duinen RA Roos MP Frosch SM Greenberg 2006 The cerebral beta-amyloid angiopathies: hereditary and sporadic Brain Pathol 16 30 39 10.1111/j.1750-3639.2006.tb00559.x 16612980 1:CAS:528:DC%2BD28XpsFeisbk%3D 10.1111/j.1750-3639.2006.tb00559.x
99. L Cabrejo P Chassagne J Doucet A Laquerrière N Puech D Hannequin 2006 Sporadic cerebral amyloidotic angiopathy Rev Neurol (Paris) 162 1059 1067 10.1016/S0035-3787(06)75118-9 1:STN:280:DC%2BD28nlt1ektA%3D%3D
100. B Bukau J Weissman A Horwich 2006 Molecular chaperones and protein quality control Cell 125 443 451 10.1016/j.cell.2006.04.014 16678092 1:CAS:528:DC%2BD28XkslCjtLw%3D 10.1016/j.cell.2006.04.014
101. NF Bence RM Sampat RR Kopito 2001 Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 1552 1555 10.1126/science.292.5521. 1552 11375494 1:CAS:528:DC%2BD3MXktVyqs74%3D 10.1126/science.292.5521.1552 (Pubitemid 32493425)
102. MY Sherman AL Goldberg 2001 Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases Neuron 29 15 32 10.1016/S0896-6273(01)00177-5 11182078 1:CAS:528:DC%2BD3MXisleis7k%3D 10.1016/S0896-6273(01)00177-5 (Pubitemid 32108719)
103. M Gross DK Wilkins MC Pitkeathly EW Chung C Higham A Clark CM Dobson 1999 Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB Protein Sci 8 1350 1357 10.1110/ps.8.6.1350 10386885 1:CAS:528:DyaK1MXjvF2gsro%3D 10.1110/ps.8.6.1350
104. MR Krebs DK Wilkins EW Chung MC Pitkeathly AK Chamberlain J Zurdo CV Robinson CM Dobson 2000 Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain J Mol Biol 300 541 549 10.1006/jmbi.2000.3862 10884350 1:CAS:528:DC%2BD3cXksFKgurY%3D 10.1006/jmbi.2000.3862 (Pubitemid 30695625)
105. TA Pertinhez M Bouchard EJ Tomlinson R Wain SJ Ferguson CM Dobson LJ Smith 2001 Amyloid fibril formation by a helical cytochrome FEBS Lett 495 184 186 10.1016/S0014-5793(01)02384-5 11334888 1:CAS:528:DC%2BD3MXjtFGht7g%3D 10.1016/S0014-5793(01)02384-5 (Pubitemid 32397701)
106. J Zurdo JI Guijarro JL Jiménez HR Saibil CM Dobson 2001 Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain J Mol Biol 311 325 340 10.1006/jmbi.2001.4858 11478864 1:CAS:528: DC%2BD3MXlsFChu7Y%3D 10.1006/jmbi.2001.4858 (Pubitemid 32744545)
107. S Srisailam TK Kumar D Rajalingam KM Kathir HS Sheu FJ Jan PC Chao C Yu 2003 Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation J Biol Chem 278 17701 17709 10.1074/jbc.M300336200 12584201 1:CAS:528:DC%2BD3sXjs1Kitro%3D 10.1074/jbc.M300336200 (Pubitemid 36799372)
108. M Fändrich V Forge K Buder M Kittler CM Dobson S Diekmann 2003 Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments Proc Natl Acad Sci USA 100 15463 15468 10.1073/pnas.0303758100 14665689 10.1073/pnas.0303758100 1:CAS:528:DC%2BD2cXhtVequw%3D%3D (Pubitemid 38021012)
109. JI Guijarro M Sunde JA Jones ID Campbell CM Dobson 1998 Amyloid fibril formation by an SH3 domain Proc Natl Acad Sci USA 95 4224 4228 10.1073/pnas.95.8.4224 9539718 1:CAS:528:DyaK1cXis1OhtLw%3D 10.1073/pnas.95.8. 4224 (Pubitemid 28207893)
110. DM Fowler AV Koulov WE Balch JW Kelly 2007 Functional amyloid from bacteria to humans Trends Biochem Sci 32 217 224 10.1016/j.tibs.2007.03.003 17412596 1:CAS:528:DC%2BD2sXlt1aitrs%3D 10.1016/j.tibs.2007.03.003 (Pubitemid 46694328)
111. JF Berson AC Theos DC Harper D Tenza G Raposo MS Marks 2003 Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis J Cell Biol 161 521 533 10.1083/jcb.200302072 12732614 1:CAS:528:DC%2BD3sXjvVeqsL8%3D 10.1083/jcb.200302072 (Pubitemid 36578577)
112. DM Fowler AV Koulov C Alory-Jost MS Marks WE Balch JW Kelly 2006 Functional amyloid formation within mammalian tissue PLoS Biol 4 e6 16300414 10.1371/journal.pbio.0040006 1:CAS:528:DC%2BD28XntVegtg%3D%3D (Pubitemid 43128321)
113. ZH Lee L Hou G Moellmann E Kuklinska K Antol M Fraser R Halaban BS Kwon 1996 Characterization and subcellular localization of human Pmel 17/silver, a 110-kDa (pre)melanosomal membrane protein associated with 5,6,-dihydroxyindole- 2-carboxylic acid (DHICA) converting activity J Invest Dermatol 106 605 610 10.1111/1523-1747.ep12345163 8617992 1:CAS:528:DyaK28XislKqsLw%3D 10.1111/1523-1747.ep12345163
114. VH Perry C Cunningham D Boche 2002 Atypical inflammation in the central nervous system in prion disease Curr Opin Neurol 15 349 354 10.1097/00019052- 200206000-00020 12045736 10.1097/00019052-200206000-00020 (Pubitemid 34596901)
115. J Maeda B Ji T Irie T Tomiyama M Maruyama T Okauchi M Staufenbiel N Iwata M Ono TC Saido K Suzuki H Mori M Higuchi T Suhara 2007 Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography J Neurosci 27 10957 10968 10.1523/JNEUROSCI.0673-07.2007 17928437 1:CAS:528:DC%2BD2sXht1Wnsb7J 10.1523/JNEUROSCI.0673-07.2007 (Pubitemid 47574168)
116. CA von Arnim R Spoelgen ID Peltan M Deng S Courchesne M Koker T Matsui H Kowa SF Lichtenthaler MC Irizarry BT Hyman 2006 GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing J Neurosci 26 9913 9922 10.1523/JNEUROSCI.2290-06.2006 10.1523/JNEUROSCI.2290-06.2006 1:CAS:528:DC%2BD28XhtVOmtLnJ (Pubitemid 44477153)
117. LA Morozova-Roche 2007 Equine lysozyme: the molecular basis of folding, self-assembly and innate amyloid toxicity FEBS Lett 581 2587 2592 10.1016/j.febslet.2007.05.023 17531977 1:CAS:528:DC%2BD2sXmtFOitb4%3D 10.1016/j.febslet.2007.05.023 (Pubitemid 46829117)
118. R Wetzel 2006 Kinetics and thermodynamics of amyloid fibril assembly Acc Chem Res 39 671 679 10.1021/ar050069h 16981684 1:CAS:528:DC%2BD28XntFahsb0%3D 10.1021/ar050069h
119. S Magaki R Raghavan C Mueller KC Oberg HV Vinters WM Kirsch 2007 Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias Neurosci Lett 418 72 76 10.1016/j.neulet.2007.02.077 17408857 1:CAS:528:DC%2BD2sXkslWqurY%3D 10.1016/j.neulet.2007.02.077 (Pubitemid 46602696)
120. YM Kuo F Crawford M Mullan TA Kokjohn MR Emmerling RO Weller AE Roher 2000 Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease Mol Med 6 430 439 10952022 1:CAS:528:DC%2BD3cXmtVakurg%3D
121. E Matsubara C Soto S Governale B Frangione J Ghiso 1996 Apolipoprotein J and Alzheimer's amyloid beta solubility Biochem J 316 671 679 8687416 1:CAS:528:DyaK28XjvVahtbo%3D
122. AT Alexandrescu 2005 Amyloid accomplices and enforcers Protein Sci 14 1 12 10.1110/ps.04887005 15576561 1:CAS:528:DC%2BD2MXhtFWguw%3D%3D 10.1110/ps.04887005 (Pubitemid 40054111)
123. B Lindahl L Eriksson U Lindhal 1995 Structure of heparan sulfate from human brain, with special regard to Alzheimer's disease Biochem J 306 177 184 7864807 1:CAS:528:DyaK2MXjvVWktr0%3D
124. J Mas-Oliva KS Arnold WD Wagner DR Phillips RE Pitas TL Innerarity 1994 Isolation and characterization of a platelet-derived macrophage-binding proteoglycan J Biol Chem 269 10177 10183 8144520 1:CAS:528:DyaK2cXkt12nt7c%3D
125. S Bussini L Meda E Scarpini E Clementi G Conti M Tiriticco N Bresolin P Baron 2005 Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by murine microglia Immun Ageing 2 11 10.1186/1742-4933-2-11 16022734 10.1186/1742-4933-2-11 1:CAS:528:DC%2BD2MXmvFehsLk%3D (Pubitemid 44848800)
126. AD Snow TN Wight 1989 Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses Neurobiol Aging 10 481 497 10.1016/0197-4580(89) 90108-5 2682326 1:CAS:528:DyaL1MXmt12rt74%3D 10.1016/0197-4580(89)90108-5 (Pubitemid 19245453)
127. GM Castillo C Ngo J Cummings TN Wight AD Snow 1997 Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril
128. JB Ancsin 2003 Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit Amyloid 10 67 79 12964414 1:CAS:528:DC%2BD3sXntlCitb8%3D
129. M Arrasate M Pérez JM Valpuesta J Avila 1997 Role of glycosaminoglycans in determining the helicity of paired helical filaments Am J Pathol 151 1115 1122 9327745 1:CAS:528:DyaK2sXmvFGmu70%3D
130. G Brückner D Hausen W Härtig M Drlicek T Arendt K Brauer 1999 Cortical areas abundant in extracellular matrix chondroitin sulfate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease Neuroscience 92 791 805 10.1016/S0306-4522(99)00071-8 10426522 10.1016/S0306-4522(99)00071-8 (Pubitemid 29287527)
131. AD Snow RT Sekiguchi D Nochlin RN Kalaria K Kimata 1994 Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain Am J Pathol 144 337 347 8311117 1:STN:280: DyaK2c7ksVKrtg%3D%3D
132. AD Snow R Sekiguchi D Nochlin P Fraser K Kimata A Mizutani M Arai WA Scherier DG Morgan 1994 An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain Neuron 12 219 234 10.1016/0896-6273(94)90165-1 8292358 1:CAS:528:DyaK2cXivFGrsLY%3D 10.1016/0896-6273(94)90165-1
133. M Kvansakul M Hopf A Ries R Timpl E Hohenester 2001 Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan EMBO J 20 5342 5346 10.1093/emboj/20.19.5342 11574465 1:CAS:528:DC%2BD38XjtVSruw%3D%3D 10.1093/emboj/20.19.5342 (Pubitemid 32959453)
134. S Potter-Perigo RL Hull C Tsoi KR Braun S Andrikopoulos J Teague C Bruce Verchere SE Kahn TN Wight 2003 Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin Arch Biochem Biophys 413 182 190 10.1016/S0003-9861(03)00116-4 12729615 1:CAS:528:DC%2BD3sXjt1Kjt7c%3D 10.1016/S0003-9861(03)00116-4 (Pubitemid 36506806)
135. GM Castillo JA Cummings W Yang ME Judge MJ Sheardown K Rimvall JB Hansen AD Snow 1998 Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation Diabetes 47 612 620 10.2337/diabetes.47.4.612 9568695 1:CAS:528:DyaK1cXit1GnsLw%3D 10.2337/diabetes.47.4.612 (Pubitemid 28160453)
136. S Yamamoto I Yamaguchi K Hasegawa S Tsutsumi Y Goto F Gejyo H Naiki 2004 Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH J Am Soc Nephrol 15 126 133 10.1097/01.ASN.0000103228.81623.C7 14694164 1:CAS:528:DC%2BD2cXhs1ahsw%3D%3D 10.1097/01.ASN.0000103228.81623.C7 (Pubitemid 38020704)
137. JY Suk F Zhang WE Balch RJ Linhardt JW Kelly 2006 Heparin accelerates gelsolin amyloidogenesis Biochemistry 45 2234 2242 10.1021/bi0519295 16475811 1:CAS:528:DC%2BD28XoslOhtA%3D%3D 10.1021/bi0519295 (Pubitemid 43271322)
138. PE Fraser JT Nguyen DT Chin DA Kirschner 1992 Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions J Neurochem 59 1531 1540 10.1111/j.1471-4159. 1992.tb08470.x 1402902 1:CAS:528:DyaK38XmtlWmsLg%3D 10.1111/j.1471-4159.1992. tb08470.x
139. WD McCubbin CM Kay S Narindrasorasak R Kisilevsky 1988 Circular-dichroism studies on two murine serum amyloid A proteins Biochem J 256 775 783 3223951 1:CAS:528:DyaL1MXlslKj
140. R Gupta-Bansal RC Frederickson KR Brunden 1995 Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation J Biol Chem 270 18666 18671 10.1074/jbc.270.31.18666 7629198 1:CAS:528:DyaK2MXntlGjsrc%3D 10.1074/jbc.270.31.18666
141. JB Ancsin R Kisilevsky 1999 The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis J Biol Chem 274 7172 7181 10.1074/jbc.274.11.7172 10066777 1:CAS:528:DyaK1MXhvFWqsLk%3D 10.1074/jbc.274.11.7172 (Pubitemid 29140531)
142. JT Jarrett EP Berger PT Lansbury Jr 1993 The C-terminus of the beta protein is critical in amyloidogenesis Ann N Y Acad Sci 695 144 148 10.1111/j.1749-6632.1993.tb23043.x 8239273 1:CAS:528:DyaK2cXltFaltA%3D%3D 10.1111/j.1749-6632.1993.tb23043.x (Pubitemid 23348252)
143. DJ Selkoe 1994 Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease Annu Rev Cell Biol 10 373 403 10.1146/annurev.cb.10.110194.002105 7888181 1:CAS:528:DyaK2MXitlSnsb4%3D 10.1146/annurev.cb.10.110194.002105
144. SS Sisodia 1992 Beta-amyloid precursor protein cleavage by a membrane-bound protease Proc Natl Acad Sci USA 89 6075 6079 10.1073/pnas.89.13. 6075 1631093 1:CAS:528:DyaK38XltV2gsLk%3D 10.1073/pnas.89.13.6075
145. JA Hardy GA Higgins 1992 Alzheimer's disease: the amyloid cascade hypothesis Science 256 184 185 10.1126/science.1566067 1566067 1:CAS:528:DyaK38Xitlarurg%3D 10.1126/science.1566067
146. J Santiago-García J Mas-Oliva TL Innerarity RE Pitas 2001 Secreted forms of the amyloid - precursor protein are ligands for the A scavenger receptor J Biol Chem 276 30655 30661 10.1074/jbc.M102879200 11389145 10.1074/jbc.M102879200
147. N Manzano-León NB Delgado-Coello M Guaderrama-Díaz J Mas-Oliva 2006 Beta-adaptin: key molecule for microglial scavenger receptor function under oxidative stress Biochem Biophys Res Commun 351 588 594 10.1016/j.bbrc.2006.10.077 17092488 10.1016/j.bbrc.2006.10.077 1:CAS:528:DC%2BD28Xht1SmsbbP (Pubitemid 44708850)
148. J Varga MS Flinn T Shirahama OG Rodgers AS Cohen 1986 The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor Virchows Arch B Cell Pathol Incl Mol Pathol 51 177 185 10.1007/BF02899027 2874651 1:CAS:528:DyaL28XltlWrtb4%3D 10.1007/BF02899027
149. K Ganowiak P Hultman U Engström A Gustavsson P Westermark 1994 Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice Biochem Biophys Res Commun 199 306 312 10.1006/bbrc.1994.1229 8123028 1:CAS:528:DyaK2cXhvVyku78%3D 10.1006/bbrc.1994. 1229 (Pubitemid 24179949)
150. C Soto L Estrada J Castilla 2006 Amyloids, prions and the inherent infectious nature of misfolded protein aggregates Trends Biochem Sci 31 150 155 10.1016/j.tibs.2006.01.002 16473510 1:CAS:528:DC%2BD28Xit1yms7Y%3D 10.1016/j.tibs.2006.01.002 (Pubitemid 43357995)
151. SB Prusiner 1997 Prion diseases and the BSE crisis Science 278 245 251 10.1126/science.278.5336.245 9323196 1:CAS:528:DyaK2sXms1Cqs7w%3D 10.1126/science.278.5336.245 (Pubitemid 27450864)
152. FE Cohen SB Prusiner 1998 Pathologic conformations of prion proteins Annu Rev Biochem 67 793 819 10.1146/annurev.biochem.67.1.793 9759504 1:CAS:528:DyaK1cXlsFOmsbc%3D 10.1146/annurev.biochem.67.1.793 (Pubitemid 28411145)
153. B Ghetti P Piccardo B Frangione O Bugiani G Giaccone K Young F Prelli MR Farlow SR Dlouhy F Tagliavini 1996 Prion protein amyloidosis Brain Pathol 6 127 145 10.1111/j.1750-3639.1996.tb00796.x 8737929 1:CAS:528:DyaK28XivFykurw%3D 10.1111/j.1750-3639.1996.tb00796.x (Pubitemid 26161871)
154. EP Richardson CL Masters 1995 The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system Brain Pathol 5 33 41 10.1111/j.1750-3639.1995.tb00575.x 7767489 10.1111/j.1750-3639. 1995.tb00575.x
155. SJ DeArmond SB Prusiner 1995 Prion protein transgenes and the neuropathology in prion diseases Brain Pathol 5 77 89 10.1111/j.1750-3639.1995. tb00579.x 7767493 1:STN:280:DyaK2M3osFSjsg%3D%3D 10.1111/j.1750-3639.1995. tb00579.x
156. G Giaccone L Verga O Bugiani B Frangione D Serban SB Prusiner MR Farlow B Ghetti F Tagliavini 1992 Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred Proc Natl Acad Sci USA 89 9349 9353 10.1073/pnas.89.19.9349 1357663 1:CAS:528:DyaK3sXltVaj 10.1073/pnas.89.19.9349
157. T Revesz J Ghiso T Lashley G Plant A Rostagno B Frangione JL Holton 2003 Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view J Neuropathol Exp Neurol 62 885 898 14533778 1:CAS:528:DC%2BD3sXotF2ks7s%3D
158. YC Liao RV Lebo GA Clawson EA Smuckler 1986 Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications Science 233 364 367 10.1126/science.3014653 3014653 1:CAS:528:DyaL28XltV2kurY%3D 10.1126/science.3014653
159. SB Prusiner 1991 Molecular biology of prion diseases Science 252 1515 1522 10.1126/science.1675487 1675487 1:CAS:528:DyaK3MXksVKqsbo%3D 10.1126/science.1675487
160. KM Pan M Baldwin J Nguyen M Gasset A Serban D Groth I Mehlhorn Z Huang RJ Fletterick FE Cohen SB Prusiner 1993 Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins Proc Natl Acad Sci USA 90 10962 10966 10.1073/pnas.90.23.10962 7902575 1:CAS:528:DyaK2cXkvVCnug%3D%3D 10.1073/pnas.90.23.10962 (Pubitemid 23354348)
161. M Gasset MA Baldwin DH Lloyd JM Gabriel DM Holtzman F Cohen R Fletterick SB Prusiner 1992 Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid Proc Natl Acad Sci USA 89 10940 10944 10.1073/pnas.89.22.10940 1438300 1:CAS:528:DyaK3sXns1OjtA%3D%3D 10.1073/pnas.89.22.10940
162. H Büeler M Fischer Y Lang H Bluethmann HP Lipp SJ DeArmond SB Prusiner 1992 Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein Nature 356 577 582 10.1038/356577a0 1373228 10.1038/356577a0
163. H Büeler A Aguzzi A Sailer RA Greiner P Autenried M Aguet C Weissmann 1993 Mice devoid of PrP are resistant to scrapie Cell 73 1339 1347 10.1016/0092-8674(93)90360-3 8100741 10.1016/0092-8674(93)90360-3 (Pubitemid 23201147)
164. SB Prusiner MP McKinley KA Bowman DC Bolton PE Bendheim DF Groth GG Glenner 1983 Scrapie prions aggregate to form amyloid-like birefringent rods Cell 35 349 358 10.1016/0092-8674(83)90168-X 6418385 1:CAS:528: DyaL2cXjtF2msQ%3D%3D 10.1016/0092-8674(83)90168-X
165. SJ DeArmond MP McKinley RA Barry MB Braunfeld JR McColloch SB Prusiner 1985 Identification of prion amyloid filaments in scrapie-infected brain Cell 41 221 235 10.1016/0092-8674(85)90076-5 3922627 1:STN:280:DyaL2M3gtFKksQ%3D%3D 10.1016/0092-8674(85)90076-5
166. C Wasmer A Lange H Van Melckebeke AB Siemer R Riek BH Meier 2008 Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core Science 319 1523 1526 10.1126/science.1151839 18339938 1:CAS:528:DC%2BD1cXjtVGqsrs%3D 10.1126/science.1151839
167. X Hou MI Aguilar DH Small 2007 Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration FEBS J 274 1637 1650 10.1111/j.1742-4658.2007.05712.x 17381508 1:CAS:528:DC%2BD2sXksFSmurg%3D 10.1111/j.1742-4658.2007.05712.x (Pubitemid 46426902)
168. PP Costa AS Figueira FR Bravo 1978 Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy Proc Natl Acad Sci USA 75 4499 4503 10.1073/pnas.75.9.4499 279930 1:CAS:528:DyaE1cXlvFCqsb4%3D 10.1073/pnas.75.9.4499
169. MM Sousa I Cardoso R Fernandez A Guimäraes MJ Saraiva 2001 Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates Am J Pathol 159 1993 2000 11733349 1:CAS:528:DC%2BD38Xhslakuw%3D%3D
170. HL Monaco 2002 Three-dimensional structure of the transthyretin-retinol- binding protein complex Clin Chem Lab Med 40 1229 1236 10.1515/CCLM.2002.213 12553423 1:CAS:528:DC%2BD3sXhsFGmsL0%3D 10.1515/CCLM.2002.213 (Pubitemid 36024660)
171. C Redondo AM Damas MJ Saraiva 2000 Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity Biochem J 348 167 172 10.1042/0264-6021:3480167 10794728 1:CAS:528:DC%2BD3cXjvFeisrw%3D 10.1042/0264-6021:3480167 (Pubitemid 30312145)
172. DR Jacobson RD Pastore R Yaghoubian I Kane G Gallo FS Buck JN Buxbaum 1997 Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans N Engl J Med 336 466 473 10.1056/ NEJM199702133360703 9017939 1:STN:280:DyaK2s7mtV2htg%3D%3D 10.1056/ NEJM199702133360703 (Pubitemid 27074357)
173. JN Buxbaum CE Tagoe 2000 The genetics of the amyloidoses Annu Rev Med 51 543 569 10.1146/annurev.med.51.1.543 10774481 1:CAS:528:DC%2BD3cXisVelt7g%3D 10.1146/annurev.med.51.1.543 (Pubitemid 30216054)
174. JW Kelly W Colon Z Lai HA Lashuel J McCulloch SL McCutchen GJ Miroy SA Peterson 1997 Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid Adv Protein Chem 50 161 181 10.1016/S0065-3233(08)60321-6 9338081 1:CAS:528:DyaK2sXotVyktrk%3D 10.1016/S0065-3233(08)60321-6
175. JW Kelly 1998 The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr Opin Struct Biol 8 101 106 10.1016/S0959-440X(98)80016-X 9519302 1:CAS:528:DyaK1cXhvVWru7w%3D 10.1016/S0959-440X(98)80016-X (Pubitemid 28107921)
176. N Reixach S Deechongkit X Jian JW Kelly JN Buxbaum 2004 Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture Proc Natl Acad Sci USA 101 2817 2822 10.1073/pnas.0400062101 14981241 1:CAS:528:DC%2BD2cXitlWhs74%3D 10.1073/pnas.0400062101 (Pubitemid 38327694)
177. JW Kelly 1997 Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases Structure 5 595 600 10.1016/S0969-2126(97)00215-3 9195890 1:CAS:528:DyaK2sXjvFamt70%3D 10.1016/S0969-2126(97)00215-3
178. WC Nichols FE Dwulet J Liepnieks MD Benson 1988 Variant apolipoprotein AI as a major constituent of a human hereditary amyloid Biochem Biophys Res Commun 156 762 768 10.1016/S0006-291X(88)80909-4 3142462 1:CAS:528: DyaL1MXjslCjtw%3D%3D 10.1016/S0006-291X(88)80909-4 (Pubitemid 18263896)
179. PD Gorevic PC Munoz G Gorgone JJ Purcell Jr M Rodrigues J Ghiso E Levy M Haltia B Frangione 1991 Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II N Engl J Med 325 1780 1785 1658654 1:STN:280:DyaK38%2FkvFKguw%3D%3D
180. E Levy M Haltia I Fernandez-Madrid O Koivunen J Ghiso F Prelli B Frangione 1990 Mutation in gelsolin gene in Finnish hereditary amyloidosis J Exp Med 172 1865 1867 10.1084/jem.172.6.1865 2175344 1:CAS:528:DyaK3cXmtV2gtLc%3D 10.1084/jem.172.6.1865
181. A de la Chapelle R Tolvanen G Boysen J Santavy L Bleeker-Wagemakers CP Maury J Kere 1992 Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187 Nat Genet 2 157 160 10.1038/ng1092-157 1338910 10.1038/ng1092-157
182. T Wisniewski A Golabek E Kida K Wisniewski B Frangione 1995 Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis Am J Pathol 147 238 244 7639323 1:CAS:528:DyaK2MXns1Wnsbc%3D
183. CP Maury J Kere R Tolvanen A de la Chapelle 1990 Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene FEBS Lett 276 75 77 10.1016/0014-5793(90)80510-P 2176164 1:CAS:528: DyaK3MXls1OjtA%3D%3D 10.1016/0014-5793(90)80510-P
184. S Kiuru 1998 Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide Amyloid 5 55 66 9547007 1:STN:280: DyaK1c7otFKhsg%3D%3D
185. 2+ stabilization EMBO J 20 6277 6287 10.1093/emboj/20.22.6277 11707399 1:CAS:528:DC%2BD3MXovFOnt7g%3D 10.1093/emboj/20.22.6277 (Pubitemid 33078701)
186. LJ Page JY Suk ME Huff HJ Lim J Venable J Yates JW Kelly WE Balch 2005 Metalloendoprotease cleavage triggers gelsolin amyloidogenesis EMBO J 24 4124 4132 10.1038/sj.emboj.7600872 16281052 1:CAS:528:DC%2BD2MXht1yisLjJ 10.1038/sj.emboj.7600872 (Pubitemid 41752881)
187. S Bhattacharya JN Latha R Kumresan S Shashi 2007 Cloning and expression of human islet amyloid polypeptide in cultured cells Biochem Biophys Res Commun 365 8 15
188. P Westermark 1994 Amyloid and polypeptide hormones: what is their inter-relationship? Amyloid 1 47 60 10.3109/13506129409148624 1:CAS:528:DyaK2MXjtFehug%3D%3D 10.3109/13506129409148624
189. SJ Koopmans JK Radder HM Krans RM Barge 1992 Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism Neth J Med 41 82 90 1407245 1:STN:280:DyaK3s%2FisFansQ%3D%3D
190. GJ Cooper AJ Day AC Willis AN Roberts KB Reid B Leighton 1989 Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus Biochim Biophys Acta 1014 247 258 10.1016/0167-4889(89)90220-6 2690958 1:CAS:528:DyaK3cXltlSksg%3D%3D 10.1016/0167-4889(89)90220-6 (Pubitemid 20009797)
191. BJ Edwards JE Morley 1992 Amylin Life Sci 51 1899 1912 10.1016/0024-3205(92)90106-Y 1453875 1:CAS:528:DyaK3sXitVSrsA%3D%3D 10.1016/0024-3205(92)90106-Y
192. MR Nilsson DP Raleigh 1999 Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin J Mol Biol 294 1375 1385 10.1006/jmbi.1999.3286 10600392 1:CAS:528:DyaK1MXnvFaru7Y%3D 10.1006/jmbi.1999.3286 (Pubitemid 30008807)
193. M Anguiano RJ Nowak PT Lansbury 2002 Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes Biochemistry 41 11338 11343 10.1021/bi020314u 12234175 1:CAS:528:DC%2BD38XmtlynsL4%3D 10.1021/bi020314u (Pubitemid 35050739)
194. P Westermark C Wernstedt E Wilander DW Hayden TD O'Brien KH Johnson 1987 Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proc Natl Acad Sci USA 84 3881 3885 10.1073/pnas.84.11.3881 3035556 1:CAS:528:DyaL2sXksFKrtr0%3D 10.1073/pnas.84.11.3881 (Pubitemid 17088383)
195. C Rosano S Zuccotti M Bolognesi 2005 The three-dimensional structure of β2 microglobulin: results from X ray crystallography Biochim Biophys Acta 1753 85 91 16084780 1:CAS:528:DC%2BD2MXht1Sru77L
196. J Floege G Ehlerding 1996 Beta-2-microglobulin associated amyloidosis Nephron 72 9 26 10.1159/000188801 8903856 1:CAS:528:DyaK28XhtVWqsrs%3D 10.1159/000188801
197. F Gejyo T Yamada S Odani Y Nakagawa M Arakawa T Kunitomo H Kataoka M Suzuki Y Hirasawa T Shirahama AS Cohen K Schmid 1985 A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin Biochem Biophys Res Commun 129 701 706 10.1016/0006-291X(85) 91948-5 3893430 1:CAS:528:DyaL2MXksFahsb0%3D 10.1016/0006-291X(85)91948-5 (Pubitemid 15243930)
198. A Gouin-Charnet G Mourad A Argilés 1997 Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation Biochem Biophys Res Commun 231 48 51 10.1006/bbrc.1996.6019 9070217 1:CAS:528:DyaK2sXht1Wrsbo%3D 10.1006/bbrc.1996. 6019 (Pubitemid 27212107)
199. CH Trinh DP Smith AP Kalverda SE Philips S Radford 1991 Crystal structure of monomeric human β-2-microglobulin reveals clues to its amyloidogenic properties Proc Natl Acad Sci USA 99 9771 9776 10.1073/pnas.152337399 10.1073/pnas.152337399 1:CAS:528:DC%2BD38XlslKgs74%3D
200. VJ McParland NM Kad AP Kalverda A Brown P Kirwin-Jones MG Hunter M Sunde SE Radford 2000 Partially unfolded states of beta(2)-microglobulin amyloid formation in vitro Biochemistry 39 8735 8746 10.1021/bi000276j 10913285 1:CAS:528:DC%2BD3cXksVagtLc%3D 10.1021/bi000276j (Pubitemid 30602783)
201. Y Ohhashi Y Hagihara G Kozhukh M Hoshino K Hasegawa I Yamaguchi H Naiki Y Goto 2002 The intrachain disulfide bond of beta(2)-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH J Biochem 131 45 52 11754734 1:CAS:528:DC%2BD38Xitl2qsrc%3D
202. Gribbin JR (2004) Deep simplicity: bringing order to chaos and complexity. Random House Inc., New York, pp 1-304
203. MR Chapman LS Robinson JS Pinkner R Roth J Heuser M Hammar S Normark SJ Hultgren 2002 Role of Escherichia coli curli operons in directing amyloid fiber formation Science 295 851 855 10.1126/science.1067484 11823641 1:CAS:528:DC%2BD38XhtFaktbc%3D 10.1126/science.1067484 (Pubitemid 34118365)
204. D Claessen R Rink W de Jong J Siebring P de Vreugd FG Boersma L Dijkhuizen HA Wosten 2003 A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils Genes Dev 17 1714 1726 10.1101/gad.264303 12832396 1:CAS:528:DC%2BD3sXlslWqurw%3D 10.1101/gad.264303 (Pubitemid 36870335)
205. JP Mackay JM Matthews RD Winefield LG Mackay RG Haverkamp MD Templeton 2001 The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures Structure 9 83 91 10.1016/S0969-2126(00)00559-1 11250193 1:CAS:528:DC%2BD3MXhslKgsr4%3D 10.1016/S0969-2126(00)00559-1 (Pubitemid 32209183)
206. V Coustou C Deleu S Saupe J Begueret 1997 The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog Proc Natl Acad Sci USA 94 9773 9778 10.1073/pnas.94.18.9773 9275200 1:CAS:528:DyaK2sXlvVWgtbs%3D 10.1073/pnas.94.18.9773 (Pubitemid 27408139)
207. CY King P Tittmann H Gross R Gebert M Aebi K Wüthrich 1997 Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments Proc Natl Acad Sci USA 94 6618 6622 10.1073/pnas.94.13. 6618 9192614 1:CAS:528:DyaK2sXktF2rt74%3D 10.1073/pnas.94.13.6618 (Pubitemid 27281913)
208. VA Iconomidou G Vriend SJ Hamodrakas 2000 Amyloids protect the silkmoth oocyte and embryo FEBS Lett 479 141 145 10.1016/S0014-5793(00)01888-3 10981723 1:CAS:528:DC%2BD3cXls1GisbY%3D 10.1016/S0014-5793(00)01888-3 (Pubitemid 30616422)
209. VA Iconomidou GD Chryssikos V Gionis AS Galanis P Cordopatis A Hoenger SJ Hamodrakas 2006 Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family J Struct Biol 156 480 488 10.1016/j.jsb.2006. 08.011 17056273 1:CAS:528:DC%2BD28Xht1CgsbzE 10.1016/j.jsb.2006.08.011 (Pubitemid 44751479)
210. T Kobayashi K Urabe SJ Orlow K Higashi G Imokawa BS Kwon B Potterf VJ Hearing 1994 The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function J Biol Chem 269 29198 29205 7961886 1:CAS:528:DyaK2cXmsFans7w%3D
211. JW Kelly WE Balch 2003 Amyloid as a natural product J Cell Biol 161 461 462 10.1083/jcb.200304074 12743097 1:CAS:528:DC%2BD3sXjvVeqs7w%3D 10.1083/jcb.200304074 (Pubitemid 36578568)
212. DeLano WL (2002) The PyMOL molecular graphics system. DeLano Scientific, Palo Alto. http://www.pymol.org